| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-hydroxysteroid dehydrogenase inhibition by trilostane on Blood Pressure in the Dahl Salt Sensitive Rat
1 Research Service, G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, USA; Medicine, University of Mississippi Medical Center, Jackson, MS, USA
2 Medicine, University of Mississippi Medical Center, Jackson, MS, USA
3 Research Service, G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, USA
* To whom correspondence should be addressed. E-mail: elise.gomezsanchez{at}med.va.gov.
The brains of rats and humans express the enzymes required for the synthesis of aldosterone from cholesterol, including the 3
-steroid dehydrogenase that catalyzes the conversion of pregnenolone to progesterone in the pathway of adrenal steroid synthesis. Salt-induced hypertension in the Dahl SS/jr rat is associated with normal to low levels of circulating aldosterone, yet it is abrogated by the central infusion of mineralocorticoid receptor antagonists. To test the hypothesis that de novo synthesis of aldosterone in the brain has a pathophysiological role in the salt-induced hypertension of the SS rat, the 3-steroid dehydrogenase antagonist trilostane was infused continuously intracerebroventricularly or subcutaneously in two different cohorts of Dahl SS/jr rats, one female, the other male, during and after the development of salt-induced hypertension. The doses of trilostane used had no effect on blood pressure when infused subcutaneously. Animals receiving vehicle icv experienced a 30-45mmHg increase in systolic blood pressure measured by tail cuff. The intracerebroventricular, but not subcutaneous, infusion of 0.3µg/h trilostane effectively blocked the increase in systolic blood pressure and reversed the hypertension produced by drinking 0.9% saline. Trilostane was equally effective in female and male rats. Weight gain, serum aldosterone and corticosterone concentrations, and behavior assessed subjectively and by elevated plus maze, were unchanged by the trilostane treatment. These studies suggest that the synthesis in the brain of a mineralocorticoid receptor agonist, probably aldosterone, is responsible in part for the salt induced hypertension of the inbred Dahl SS/jr rat.
This article has been cited by other articles:
|
|
 |
|
  W. Zheng, H. Ji, C. Maric, X. Wu, and K. Sandberg Effect of dietary sodium on estrogen regulation of blood pressure in Dahl salt-sensitive rats Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1508 - H1513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Makhanova, J. Hagaman, H.-S. Kim, and O. Smithies Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase Hypertension, January 1, 2008; 51(1): 134 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Huang, W. J. Cheung, H. Wang, J. Tan, R. A. White, and F. H. H. Leenen Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar rats Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1109 - H1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Huang and F. H. H. Leenen Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2491 - H2497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Funder How do central mineralocorticoid receptors modulate blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R356 - R357. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
